ロード中...
Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid Arthritis
INTRODUCTION: Tocilizumab (TCZ) monotherapy has been proven as an effective treatment for rheumatoid arthritis (RA) in clinical trials. However, there are limited data available regarding the effectiveness of TCZ monotherapy in real-world clinical settings in the United States. The objective of this...
保存先:
| 出版年: | Rheumatol Ther |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5696293/ https://ncbi.nlm.nih.gov/pubmed/28936808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-017-0081-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|